A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder : a randomized, double-blind, placebo-controlled study
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia
Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia
Similar immune profile in bipolar disorder and schizophrenia : selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Cognitive features in euthymic bipolar patients in old age
The longitudinal course of cognition in older adults with bipolar disorder
Sexually dimorphic features of vermis morphology in bipolar disorder
Performance of the mood disorders questionnaire in a psychiatric outpatient setting
Cigarette smoking is associated with suicidality in bipolar disorder
Patient history must be incorporated into any guidelines
CANMAT guidelines : authors' response
Comment to Dr. Yatham regarding tamoxifen listed as a third-line recommendation for the pharmacological treatment of acute mania
CANMAT/ISBD treatment guidelines : response to Shen et al.
In Memoriam
STABILISING MOOD : 60 YEARS OF PROGRESS
ANTIDEPRESSANT CONTROVERSIES IN THE TREATMENT OF BIPOLAR DISORDER
WHAT ARE THE LIMITS OF PSYCHOLOGICAL INTERVENTIONS IN BIPOLAR DISORDER?
RECOVERY FROM BIPOLAR DISORDER EPISODE - WHAT DOES IT REALLY MEAN AND WHAT DOES IT LOOK LIKE?
A LAWYER AND BIPOLAR DISORDER
GLUTATHIONE AND REDOX BIOLOGY; FROM PATHOPHYSIOLOGY TO NOVEL TREATMENTS
PARTITIONING MOOD USING fMRI
INVESTIGATION OF BIOPTERIN DEFICIT IN BIPOLAR DISORDER
BIPOLAR DISORDER IN AUSTRALIA : THE 2007 NATIONAL SURVEY OF MENTAL HEALTH AND WELL-BEING
RANDOMIZED CONTROLLED TRIAL OF OLANZAPINE OR CHLORPROMAZINE AS ADDITION TO LITHIUM IN THE TREATMENT OF A FIRST MANIC EPISODE WITH PSYCHOTIC FEATURES : AN 8-WEEK, FLEXIBLE DOSE, SINGLE-BLIND TRIAL
FROM RCT TO CLINICAL PRACTICE : IMPLEMENTING AND EVALUATING AN EFFECTIVE RELAPSE PREVENTION PROGRAM FOR BIPOLAR DISORDER IN COMMUNITY SETTINGS
MANIC AND DEPRESSIVE SYMPTOM EXACERBATION AS A FUNCTION OF INTERACTION OF DYSFUNCTIONAL ATTITUDES WITH LIFE EVENTS
PAEDIATRIC BIPOLAR DISORDER : THE VIEW FROM AUSTRALIA AND NEW ZEALAND
EVALUATION OF TREATMENT OUTCOMES FROM AN AUSTRALIAN JUVENILE BIPOLAR DISORDER CLINIC
AN INVESTIGATION OF THE RELATIONSHIP BETWEEN CHILDHOOD TRAUMA AND THE 12-MONTH OUTCOME OF FIRST EPISODE MANIA IN ADOLESCENTS AND YOUNG ADULTS
BIPOLAR MOOD DISORDER AND PREGNANCY - RISKS AND RECOMMENDATIONS
POSTNATAL DEPRESSION AND BIPOLARITY
IMPROVEMENT IN DIGIT SPAN IN JUVENILE BIPOLAR DISORDER FOLLOWING SUPPLEMENTATION WITH LONG CHAIN OMEGA-3 POLYUNSATURATED FATTY ACIDS
STAYING WELL WITH BIPOLAR DISORDER WITH A ‘STAY WELL PLAN’
PROSPECTIVE RELATIONSHIPS BETWEEN ACTIVITY, SLEEP, AND MOOD IN OUTPATIENTS WITH BIPOLAR DISORDER : AN INITIAL STEP TOWARDS THE APPLICATION OF MONITORING TECHNOLOGIES IN THE CLINICAL SETTING
BCOS GENDER MATTERS : PRESENTING THE PROFILE OF FEMALES WITH BIPOLAR DISORDER FROM AN AUS-TRALIAN OBSERVATIONAL STUDY
THE USE OF ATYPICAL ANTIPSYCHOTICS AS AUGMENTATION THERAPY IN BIPOLAR DISORDER
QUALITY OF LIFE OF PARTICIPANTS WITH BIPOLAR AND SCHIZOAFFECTIVE DISORDER IN AN AUSTRALIAN COHORT AFTER 24 MONTHS
TWO-YEAR TREATMENT OUTCOMES OF AN AUSTRALIAN OUTPATIENT COHORT WITH BIPOLAR I OR SCHIZOAFFECTIVE DISORDER
CELEBRATING THE CONSUMER MOVEMENT OF PEOPLE LIVING WITH BIPOLAR DISORDER
FACING POTENTIAL BIPOLAR DISORDER? N170 EVENT-RELATED POTENTIAL VARIANCES DURING EMOTIONAL FACE PROCESSING IN BIPOLAR DISORDER
VALIDITY OF A PAEDIATRIC QUALITY OF LIFE QUESTIONNAIRE FOR PARTICIPANTS WITH JUVENILE BIPOLAR DISORDER
ATTACHMENT THEORY AND TRAUMA IN THE PAEDIATRIC BIPOLAR DISORDER LITERATURE
PREDICTORS OF ENGAGEMENT IN PSYCHOLOGICAL THERAPY FOR FIRST EPISODE BIPOLAR DISORDER
BIPOLAR DISORDER IS ASSOCIATED WITH A HIGHER DIETARY GLYCEMIC LOAD
RANDOMISED, PLACEBO-CONTROLLED, LONG-TERM STUDY OF RISPERIDONE LONG ACTING INJECTABLE IN RELAPSE PREVENTION IN BIPOLAR DISORDER PATIENTS
DEVELOPMENT OF GUIDELINES FOR CARERS OF ADULTS WITH BIPOLAR DISORDER
DOES TOBACCO SMOKING MAKE BIPOLAR DISORDER WORSE? EVIDENCE FROM CLINICAL STUDIES